메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Joon Hyun Cho (Division of Gastroenterology and Hepatology Department of Internal Medicine Yeungnam University Col) Mohammad Bilal (Center for Advanced Endoscopy Division of Gastroenterology Beth Israel Deaconess Medical Center Har) Min Cheol Kim (Division of Gastroenterology and Hepatology Department of Internal Medicine Yeungnam University Col) Jonah Cohen (Center for Advanced Endoscopy Division of Gastroenterology Beth Israel Deaconess Medical Center Har)
저널정보
대한소화기내시경학회 Clinical Endoscopy Clinical Endoscopy 제54권 제1호
발행연도
2021.1
수록면
9 - 16 (8page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Obesity is becoming increasingly prevalent worldwide, and its metabolic sequelae lead to a significant burden on healthcareresources. Options for the management of obesity include lifestyle modification, pharmacological treatment, surgery, and endoscopicbariatric therapies (EBTs). Among these, EBTs are more effective than diet and lifestyle modification and are less invasive thanbariatric surgery. In recent years, there have been significant advances in technologies pertaining to EBTs. Of all the available EBTs,there is a significant amount of clinical experience and published data regarding intragastric balloons (IGBs) because of theircomparatively long development period. Currently, the United States Food and Drug Administration (FDA) has approved threeIGBs, including Orbera (Apollo Endosurgery, Austin, TX, USA), ReShape Duo (ReShape Medical, San Clemente, CA, USA), andObalon (Obalon Therapeutics, Carlsbad, CA, USA). The aim of this review is to summarize the available literature on the efficacy ofIGBs in weight loss and their impact on obesity-related metabolic diseases.

목차

등록된 정보가 없습니다.

참고문헌 (72)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0